Pneumococcal vaccine and HIV-1 infection

被引：2

作者：

Fedson, DS ^{[1
]}

Watson, M

机构：

[1] Aventis Pasteur MSD, F-69367 Lyon 07, France

[2] Aventis Pasteur MSD, Maidenhead, Berks, England

来源：

LANCET | 2000年 / 356卷 / 9237期

关键词：

D O I：

10.1016/S0140-6736(05)73873-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：1272 / 1272

页数：1

相关论文

共 5 条

[1] BREIMAN RF, IN PRESS ARCH INTERN
[2] 23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial
French, N
Nakiyingi, J
Carpenter, LM
Lugada, E
Watera, C
Moi, K
Moore, M
Antvelink, D
Mulder, D
Janoff, EN
Whitworth, J
Gilks, CF
[J]. LANCET, 2000, 355 (9221) : 2106 - 2111
[3] The impact of HIV on Streptococcus pneumoniae bacteraemia in a South African population
Jones, N
Huebner, R
Khoosal, M
Crewe-Brown, H
Klugman, K
[J]. AIDS, 1998, 12 (16) : 2177 - 2184
[4] Do bacterial pneumonia and Pneumocystis carinii pneumonia accelerate progression of human immunodeficiency virus disease?: Editorial response
Kaplan, JE
Janoff, EN
Masur, H
[J]. CLINICAL INFECTIOUS DISEASES, 1999, 29 (03) : 544 - 546
[5] Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California
Nuorti, JP
Butler, JC
Gelling, L
Kool, JL
Reingold, AL
Vugia, DJ
[J]. ANNALS OF INTERNAL MEDICINE, 2000, 132 (03) : 182 - 190